Paradoxically, however, investigators have recognized that the survival rate of patients with advanced gastric cancer who are HP+ is higher than that for HP- patients from studies carried out in a variety of countries that have varying HP genotype and diet as well as different therapeutic strategies for advanced gastric cancer [2–8]. Here, HP is linked to gastric cancer.